We recently cloned and sequenced a cDNA encoding a 145-kD protein from the murine hematopoietic cell line B6SUtAI that becomes tyrosine phosphorylated and associated with Shc after cytokine stimulation. Based on its domains and enzymatic activity, we named this protein SHIP for SH2-containing inositol phosphatase (Damen et al, Proc Natl Aced Sci USA 93:1689, 1996). We describe here the cloning of the human homologue of murine SHIP (mSHIP) from a human megakaryocytic cell line (M07e) Xgtll cDNA library using two nonoverlapping mSHlP cDNA fragments as probes. Northern blot analysis suggests that human SHIP (hSHIP) is expressed as a 5.3-kb mRNA in human bone mar-ANY GROWTH FACTORS mediate their effects on M target cells by binding to cell surface receptors that contain endogenous tyrosine kinase domains. After binding, these receptors dimerize, intermolecularly autophosphorylate, and then attract cytoplasmic proteins containing Src homology 2 (SH2) or phosphotyrosine binding (PTB) domains to initiate various intracellular signalling cascades.'" One of the best characterized of these cascades is the Ras p a t h~a y ,~.~ and two SH2 containing adapter proteins, Grb2 and Shc, have been implicated in its activation. These proteins have been shown to bind directly to tyrosine phosphorylated receptors or SH2 docking proteins (such as the insulin receptor substrate-1 [IRS-11) and to mediate the translocation of a Ras guanine nucleotide exchange factor, Sosl, to the plasma membrane, where it activates Ras by catalyzing the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) . 536
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In preliminary studies with the human hematopoietic cell lines M07e and TF-1, we also observed a 145-kD protein row and a wide variety of other tissues. Sequence analysis of this cDNA predicts a protein of 1188 amino acids exhibiting 87.2% overall sequence identity with mSHIP. Contained within the defined open reading frame is an N-terminal, group I src homology 2 (SH2) domain; three NXXY motifs that, if phosphorylated, could be bound by phosphotyrosine binding (PTB) domains; a C-terminal proline-rich region; and two centrally located inositol polyphosphate 5-phosphatase motifs. Fluorescence in situ hybridization, using the fulllength hSHlP cDNA as a probe, mapped hSHlP to the long arm of chromosome 2 at the border between 2q36 and 2q37.
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that became tyrosine phosphorylated and associated with Shc after cytokine stimulation,'*10 suggesting that there is a human homologue of murine SHIP (mSHIP). We report here the cloning and preliminary characterization of this human SHIP (hSHIP).
MATERIALS AND METHODS
All restriction enzymes were purchased from Life Technologies/GIBCO BRL (Gaithersburg, MD). [a3*P]dCTP (3,000 Ci/mmol, 10 mCi/mL) was purchased from ICN Pharmaceuticals (Irvine, CA). All other reagents were purchased from Sigma (Mississauga, Ontario, Canada) unless otherwise indicated.
Cell lines. The M07e cell line" was routinely cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% (voY vol) fetal calf serum (FCS), 5 X lo-' mom 2-mercaptoethanol, 10% (voVvol) 5637 conditioned medium, and 5 ng/mL human interleukin-3 (IL-3). B6SUtA, ~e l l s~~~* were routinely cultured in RPMI containing 10% (voYvol) FCS and 5% (voYvo1) mouse spleen cell conditioned medium.
Duplicate nitrocellulose (Schleicher & Schuell, Keene, NH) plaque-lifts were prepared from approximately poly-A' RNA purified from M07e cells (Clontech, Palo Alto, CA). Phage DNA bound to these membranes was denatured in 0.5 N NaOH, 1.5 mol/L NaCl and hybridized for 18 hours at 50°C with nonoverlapping, [a"P]dCTP randomly labeled cDNA fragments corresponding to either 1.5 kb of the 5' region (bp 1 to 1494, which includes the SH2 domain) or 1.2 kb of the central region (bp 1495 to 2696, which includes the 5-ptase domain) of mSHIP (GenBank accession no. U39203) in 1.5X SSPE, 1% (wt/vol) sodium dodecyl sulfate (SDS), 1% (wt/vol) Blotto, and 0.25 mglmL salmon sperm DNA. The membranes were then washed three times at 50°C for 30 minutes with 0.5X SSC, 0.5% (wt/vol) SDS and exposed to Kodak X-Omat film (Eastman Kodak, Rochester, NY). Plaques that hybridized with both probes were identified and their phage was isolated. Nine cDNA inserts were removed from positive phage by EcoRl digestion and subcloned into pBluescript KS' (Statagene, La Jolla, CA) for further analysis. Two overlapping cDNA inserts that were 4,970 bp and 2,750 bp in length were chosen for further analysis. The larger of these two inserts was further digested with either Pst I or Xho I and resubcloned into pBluescript KS', and all cDNA fragments were sequenced by AB1 Prism (Perkin Elmer, Foster City, CA) automated sequencing using standard I7 and T3 oligoprimers.
Regions not overlapped by restriction fragments were sequenced using specific nucleotide oligoprimers.
Genomic DNA was isolated from murine (B6SUtA, ) and human (M07e) hematopoietic cell lines using DNAzol (GIBCO BRL) as outlined in the manufacturer's instructions and digested with individual restriction enzymes. Ten micrograms of digested DNAAane was electrophoretically separated, transferred to a Zeta-probe blotting membrane (Bio Rad Laboratories, Richmond, 
BGSUtAi
and resuspended in TRIzol (GIBCO BRL) to a final concentration of 1 X 10' cellslml. Total RNA was then isolated according to the manufacturer's instructions. Poly-A '-enriched RNA was obtained as described previously.'' Northern blot andysis. A multiple human tissue poly-A' Northem blot membrane (Clontech) originally containing 2 pg poly-A' RNAllane was hybridized with a 1.7-kb hSHlP Xho I fragment spanning the 3' end of the open reading frame (ORF) and part of the 3' untranslated region (UTR; bp 2769 to 4518). This probe was randomly labeled with [a"P]dCTP and hybridized according to the manufacturer's instructions. An additional Northern blot membrane containing 1.5 pg of human bone marrow mononuclear cell poly-A+ RNA per lane was also probed as described above.
FISH analysis was performed by the FISH Mapping Resource Centre (Hospital for Sick Children, Toronto, Ontario, Canada) on 20 well-spread human lymphocyte metaphases using the full-length hSHlP cDNA as a probe.'l)-?? The probe was biotinylated and detected with avidinfluorescein isothiocyanate (FITC). Chromosomes were counterstained with propidium iodide and 4',6-diamidin-2-phenylindol-dihydrochloride (DAPI).
Flitorrscence in sitii Ii\.l,ridizatic~i (FISH).
RESULTS AND DISCUSSION
As an initial test to confirm the presence of a human homologue of mSHIP, Southern blot analysis was performed with both murine (B6SUtA, ) and human (M07e) genomic DNA using a 1.5-kb cDNA fragment corresponding to the 3' portion of mSHIP. A comparison of the two species, shown in Fig I , showed the ability of the murine probe to crosshybridize at high stringency with human bands of similar complexity. This suggested a high degree of similarity between the two SHIP species. In addition, the uniform band intensities in each of the lanes on the human blot suggested For personal use only. on October 22, 2017. by guest www.bloodjournal.org From the presence of a single gene locus. Similar results were obtained using a 1.5-kb cDNA fragment corresponding to the 5' portion of mSHIP (data not shown).
Based on these findings, a Xgtl 1 cDNA library generated from M07e poly-A+ RNA was screened with two nonoverlapping mSHIP cDNA fragments of 1.5 and 1.2 kb, corresponding to the 5' end and central portions of mSHIP, respectively. These probes were selected because they contained the coding regions of the functionally defined SH2 and 5-ptase catalytic domains and thus were deemed likely to be highly conserved among mammalian species. From our initial screening of 1 x lo6 pfu, nine clones capable of hybridizing with both mSHIP probes were isolated and further characterized. One of these clones (clone 12, Fig 2A) contained a cDNA insert of 4,870 bp that had 128 bp of potential 5' UTR sequence; an ORF of 3,564 bp, beginning with an ATG predicted to be a good translational start sitez3; and 1,178 bp of 3' UTR sequence up to and including a poly-A tail. A second 2,750-bp clone (clone 11; Fig 2A) , partially overlapping the first and extending a further 406 bp upstream, was found to be interupted by two consecutive stop codons before another potential start codon was found, suggesting that the aforementioned start codon was in fact the most likely protein initiation site.
Conceptual translation predicted a protein of 1 188 amino acids sharing 87.2% sequence identity with mSHIP ( Fig 2B) . GenBank database searches using NCBI-BLAST identified several potential functional motifs, including an SH2 domain, three putative PTB recognition motifs, two 5-ptase motifs, and a proline-rich carboxy-terminal tail containing several potential SH3 binding consensus sequences. Sequence analysis also showed three PEST sequences and a short TAA repeat in the 3' untranslated region that closely resembles the human Alu-Sx family (Fig 2A and B) .
An examination of the hSHIP primary sequence showed that its amino-terminal SH2 domain was 93% identical to that of mSHIP at the peptide level and that it shared significant sequence identity with members of the group IB family of SH2 domains (Fig 3A) . This group includes the SH2 domains of the Ab1 family, Grb2, Tec, and TsMItk, all of which are characterized by the presence of an aromatic residue (predominantly tyrosine) at the bD5 positi~n.*~"~ This residue has recently been shown to be critical for distinguishing between the phosphopeptide specificity of group I (aromatic residue) and group I11 (aliphatic residue) SH2 domaimz6 In addition, apart from the absence of a histadine in the bD4 position, several other invariant amino acids and well-conserved basic amino acids believed to participate in SH2 domain interactions with tyrosine phosphorylated sequences' are present in both SHIP species. This finding suggests that SHIP contains a functional class I SH2 domain.
The central region of both human and mSHIP contains two motifs characteristic of 5-ptases" (indicated as boxed in motifs 1 and 2 in Fig 2B) , and a sequence comparison of these two motifs with other 5-ptases (and with several predicted translation products that share high sequence homology but have not yet been shown to possess catalytic activity) shows a high degree of similarity, especially with the recently cloned synaptojaninZ8 and the human cDNA product INPPLlZ9 (Fig 3B) . Interestingly, synaptojanin (145 kD), INPPLl (126 kD), and SHIP (145 kD) also share large regions of amino acid homology N-terminal to the 5-ptase domain, possess similar molecular masses, and, in general, have a common structure, with a central 5-ptase domain preceding a C-terminal proline-rich tail. The proline-rich regions within these three proteins most likely permit phosphorylation-independent protein-protein interactions with SH3 domain-containing proteins. This is suggested by the identification of several proline-containing sequences that constitute putative class I and class I1 SH3 domain binding motif^'^'^' in the hSHIP sequence (indicated by asterisks and solid triangles in Fig 2B) and by the finding that both mSHIPI6 and synaptojanin'' bind SH3 domains in vitro. However, SHIP is the only 5-ptase cloned to date that has an SH2 domain and that binds transiently to a growth factoractivated signalling intermediate (ie, Shc). SHIP may therefore have a unique role amongst 5-ptases in transmitting a n d or terminating growth factor-induced signals.
In this regard, both human and mSHIP contain three NXXY sequences (indicated by open triangles in Fig 2A and by solid circles in Fig 2B) that, if tyrosine phosphorylated, could serve as binding sites for PTB domain-containing proteins, most notably S~C .~' In fact, Lioubin et a134 independently isolated mSHIP using a yeast two hybrid system based on the ability of the INP NpY and ENP LpY containing regions of SHIP to bind to the Shc PTB domain. Although it is not known as yet whether the RRN QNpY sequence in SHIP can bind any PTB domain-containing protein, van der Geer et a135 recently suggested that an arginine at the -5 position greatly enhanced the affinity of NXXpYcontaining sequences for the PTB domain of Shc. Coincidentally, the tyrosine within the RRNQNY sequence is also part of a YXN sequence (underlined in Fig 1 B) that could possibly be recognized by either the Grb2 SH2 domain or, potentially, by SHIP'S own SH2 domain, because it also interacts with YXN This might enable SHIP fold over on itself to regulate the functioning of its own SH2 domain.
An analysis of the hSHIP amino acid sequence using the program PEST-FIND (PC Gene analysis software; Oxford Molecular Group, Oxford, UK) indicated the presence of three areas containing unusually high combinations of prolines (P), glutamic/aspartic acids (Em), serines (S), and threonines (T), ie, PEST sequences (indicated by solid circles in Fig 2A and shaded boxes in Fig 2B) . These regions, originally defined by Rogers et al,37 might constitute signals for rapid degradation of proteins, although more recent evidence has raised serious questions about the role of these sequences in protein degradati~n.~"."~ Interestingly, Kavanaugh et a140 very recently cloned a partial human cDNA that is nearly identical to the one we report here. They suggest that their cDNA possesses alternate start sites to yield two proteins of 145 and 130 kD. However, our cDNA, which extends 392 bp further upstream than theirs, possesses only one potential start site and contains stop codons in all three frames upstream of this start site. This strongly suggests that there is no second start site in hSHIP.
To establish the tissue expression pattern of hSHIP, a 1.7- 
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IH Synaptojanin (801) T kb fragment corresponding to the 3' end of the hSHlP cDNA (see insert in Fig 4A) was used to probe a Northern blot of poly-A'-enriched RNA from a variety of human tissues and bone marrow. This showed a single mRNA of approximately 5.3 kb in all tissues examined, with a second message of approximately 6.5 kb expressed in lung. This distribution differed from that seen for mSHIP, in which very little expression was detected in murine brain, liver, and kidney.'" In addition. a second, larger message did not appear to be present in murine lung. Importantly, the presence of hSHIP mRNA in nonhematopoietic tissues may reflect contamination by blood cells.
To determine the chromosomal location of hSHIP, primers based on the hSHlP cDNA sequence were used to perform . This led to a tentative assignment of hSHIP to chromosome 2 (data not shown). To confirm this and delineate the region within chomosome 2 where hSHlP was located. FISH was performed with human lymphocyte metaphase spreads using biotinylated full-length hSHlP cDNA and avidin-FITC. Positive hybridization signals at 2q36-37 were noted in I2 of 20 cells (60%). as determined both by analysis of the banding pattern generated by the DAPI counterstained image and by measurement of the fractional chromosome length (Fig 4B) . A search of the human chromosomal database using the NCBI-OMIM server (NCBI-Online Mendelian Inheritance in Man) identified several disorders that mapped to 2q36-37. The most intriguing of these was brachydactyly mental retardation syndrome (BMDR). This disease is characterized by a combination of mental retardation and the shortening of either the metacarpals or phalanges of the hands or of the equivalent bones in the feet, refered to as hmchymetaphaIrrgia." The gene or genes involved in BMDR have not been identified and the close proximity of hSHIP to this deletion site is intriquing in light of the recent discovery that disruption of another inositol 5-ptase, OCLR-I , leads to Lowe's oculocerebrorenal syndrome, which is also characterized, in part, by mental retardation, in conjunction with other developmental abnormalities.".n SHIP is a unique protein in many ways. With its multiple protein-protein interaction domains, its demonstrated ability to bind to the tyrosine phosphorylated form of Shc, and its PtdIns (3,4,5)P3-and Ins( I ,3,4,5)P4-specific hydrolyzing activities, it could play a significant role in regulating the changes in the levels of these two polyphosphate inositols that are observed in response to cytokine stimulation.u This, in tum. could modulate the activity of protein kinase B/ Akt.J'.'" various isoforms of protein kinase C, " the entry of extracellular calcium,'x and phosphatidylinostiol 3-kinasemediated membrane trafficking?' In addition, because SHIP For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From can potentially compete with Grb2 for binding to the activated form of S~C , ' * *~~ it could modulate the Ras pathway. We are currently exploring these possibilites by overexpressing both wild-type and various mutant forms of murine and hSHIP in different cell systems.
